3rd Quarter - Amendment

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$1,070,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 18, 2024 $970,000 Replaced
3rd Quarter - Amendment (this page) Dec 11, 2024 $1,070,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

VICP Reform and Excise Tax Inflation Reduction Act (IRA) HR7174 - Ensuring Pathways to Innovative Cures (EPIC) Act Medicare Price Setting Part D Payer Utilization Management Drug Shortages S2916 - Prescription Information Modernization Act of 2023 Vaccines, Clinical Trials and Coverage S2305 - Biosimilar Red Tape Elimination Act Biosimilar Access and Interchangeability HR 2666 - Medicaid Value Based Payments for Patients (MVP) Act HR 4758 - Accelerating Kids Access to Care Act HR 7384 - Rare Pediatric Disease Priority Review (PRV) Voucher Trade-Related Aspects of Intellectual Property Rights March-in Framework Guidance and Policies S.79 - Interagency Patent Coordination and Improvement Act of 2023 S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.150 - Affordable Prescriptions for Patients Act of 2023 S.2780 - Medication Affordability and Patent Integrity Act Digital: Data Flows and Digital Trade

LobbyistCovered position, as disclosed
PAULA BURG —
FRANCISCO CARRILLO —
STEPHEN CLAEYS —
EMILY MUELLER —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —
ANGELA BOOTHE WILES —

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 79 (118th), H.R. 4758 (118th), S. 150 (118th), S. 2780 (118th), S. 142 (118th), H.R. 7174 (118th), H.R. 2666 (118th), H.R. 7384 (118th)

Medicare/Medicaid MMM

S723/HR1458 - Access to Prescription Digital Therapeutics Act HR8816 - American Medical Innovation and Investment Act of 2024 PBM Transparency and Reform S1542/HR6283 - Delinking Revenue from Unfair Gouging (DRUG) Act HR2880 - Protecting Patients Against PBM Abuses Act HR5378 - Lower Costs More Transparency Act 340B Reform HR8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act

LobbyistCovered position, as disclosed
PAULA BURG —
FRANCISCO CARRILLO —
EMILY MUELLER —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —
ANGELA BOOTHE WILES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8816 (118th), H.R. 2880 (118th), H.R. 6283 (118th), H.R. 5378 (118th), H.R. 1458 (118th), H.R. 8574 (118th)

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act (TCJA) VICP Reform and Excise Tax VICP Transition Comprehensive Federal Tax Reform

LobbyistCovered position, as disclosed
PAULA BURG —
FRANCISCO CARRILLO —
EMILY MUELLER —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —
ANGELA BOOTHE WILES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

International Supply Chain HR4307/S2115 - Medical Supply Chain Resiliency Act

LobbyistCovered position, as disclosed
ELISSA ALBEN —
STEPHEN CLAEYS —
MATTHEW STROIA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Bills named: H.R. 4307 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.